Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...
Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Walgreens Boots ( NASDAQ: WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking to private equity confirms about debt financing for a potential takeover.
Walgreens Boots (WBA) falls 6.6% as potential takeover by Sycamore Partners unlikely to happen due to DOJ lawsuit over opioid prescriptions.
This is apparently happening to Walgreens Boots Alliance (NASDAQ: WBA), according to a media report. CNBC's David Faber ...
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...
Walgreens has faced challenges in its retail segment due to persistent inflation impacting consumer spending and has also struggled with low reimbursement rates in its pharmacy operations. These ...
Walgreens Boots Alliance has suspended its quarterly cash dividend amid restructuring efforts, the U.S. pharmacy chain ...
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
Shares of Walgreens Boots Alliance dropped 10% Friday, after the pharmacy chain suspended quarterly dividends, citing the need for cash amid litigation and turnaround efforts. The Justice Department t ...